Cardiotoxicities of Novel Therapies in Hematological Malignancies: Monoclonal Antibodies and Enzyme Inhibitors.
Prathivadhi-Bhayankaram S, Abbasi MA, Ismayl M, Marar RI, Al-Abcha A, El-Am E, Ahmad A, Acevedo AD, Ellauzi R, Villarraga H, Paludo J, Anavekar N.
Prathivadhi-Bhayankaram S, et al.
Curr Probl Cardiol. 2023 Aug;48(8):101757. doi: 10.1016/j.cpcardiol.2023.101757. Epub 2023 Apr 23.
Curr Probl Cardiol. 2023.
PMID: 37094764
Review.